https://www.marketscreener.com/quote/stock/COGNITION-THERAPEUTICS-IN-127926318/news/Cognition-Therapeutics-Announces-Dosing-of-First-Patient-in-MAGNIFY-Study-of-Oral-CT1812-for-Geograp-44309699/?utm_source=telegram&utm_medium=social&utm_campaign=share